These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10348805)

  • 41. Determination of concentration of albendazole sulfoxide in plasma and uterine fluid of heifers.
    Piscopo SE; Farin CE; Bai SA
    Am J Vet Res; 1997 Jan; 58(1):62-5. PubMed ID: 8989498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-disjunction events induced by albendazole in human cells.
    Ramírez T; Eastmond DA; Herrera LA
    Mutat Res; 2007 Jan; 626(1-2):191-5. PubMed ID: 17055335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
    Sánchez S; Alvarez L; Sallovitz J; Lanusse C
    J Vet Pharmacol Ther; 2000 Aug; 23(4):193-201. PubMed ID: 11126322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.
    Delatour P; Benoit E; Besse S; Boukraa A
    Xenobiotica; 1991 Feb; 21(2):217-21. PubMed ID: 2058177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver sulphoxidative metabolism of albendazole in rat: enantioselectivity and effect of methimazole.
    Solana HD; Sallovitz JM; Najle R; Rodriguez JA; Lanusse CE
    Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):83-8. PubMed ID: 10849890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos.
    Carlsson G; Patring J; Ullerås E; Oskarsson A
    Reprod Toxicol; 2011 Jul; 32(1):129-37. PubMed ID: 21683134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes.
    García-Rodriguez JJ; Torrado J; Bolás F
    Parasite; 2001 Jun; 8(2 Suppl):S188-90. PubMed ID: 11484352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the ionophore antibiotic monensin on the ruminal biotransformation of benzimidazole anthelmintics.
    Virkel G; Lifschitz A; Sallovitz J; Inza G; Lanusse C
    Vet J; 2004 May; 167(3):265-71. PubMed ID: 15080875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of albendazole and its metabolites on cytochromes P450 activities in rat and mouflon in vitro.
    Baliharová V; Velík J; Fimanová K; Lamka J; Szotáková B; Savlík M; Skálová L
    Pharmacol Rep; 2005; 57(1):97-106. PubMed ID: 15849383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The metabolism of albendazole in the isolated perfused intestine of rats].
    Lawrenz A; Eglit S; Kroker R
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):416-8. PubMed ID: 1425320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
    Sánchez SF; Alvarez LI; Lanusse CE
    J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cimetidine sulfoxidation in small intestinal microsomes.
    Lu X; Li C; Fleisher D
    Drug Metab Dispos; 1998 Sep; 26(9):940-2. PubMed ID: 9733675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the stereoselective fungal biotransformation of albendazole and its analysis by HPLC in polar organic mode.
    Hilário VC; Carrão DB; Barth T; Borges KB; Furtado NA; Pupo MT; de Oliveira AR
    J Pharm Biomed Anal; 2012 Mar; 61():100-7. PubMed ID: 22230802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics.
    Lanusse CE; Gascon LH; Prichard RK
    J Vet Pharmacol Ther; 1993 Mar; 16(1):38-47. PubMed ID: 8478999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers.
    Ceballos L; Krolewiecki A; Juárez M; Moreno L; Schaer F; Alvarez LI; Cimino R; Walson J; Lanusse CE
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0005945. PubMed ID: 29346367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
    Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
    J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutritional condition affects the disposition kinetics of albendazole in cattle.
    Sánchez SF; Alvarez LI; Lanusse CE
    Xenobiotica; 1996 Mar; 26(3):307-19. PubMed ID: 8730922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of feeding on the plasma disposition kinetics of the anthelmintic albendazole in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    Br Poult Sci; 2014; 55(6):824-9. PubMed ID: 25159169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.